Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Peter Pickkers and Alexandre Mebazaa.
Peter Pickkers
Connection Strength
0.498
Alexandre Mebazaa
  1. Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats. Intensive Care Med Exp. 2019 May 15; 7(1):25.
    View in: PubMed
    Score: 0.206
  2. Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects. Br J Clin Pharmacol. 2018 09; 84(9):2129-2141.
    View in: PubMed
    Score: 0.194
  3. Adrenomedullin in heart failure: pathophysiology and therapeutic application. Eur J Heart Fail. 2019 02; 21(2):163-171.
    View in: PubMed
    Score: 0.050
  4. Proenkephalin A 119-159 (Penkid) Is an Early Biomarker of Septic Acute Kidney Injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) Study. Kidney Int Rep. 2018 11; 3(6):1424-1433.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.